Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all
Topic starter
02/03/2021 9:51 pm
Trying to separate three different claims about noopept: that it is the right molecule, that it is the right dose, and that it does something useful.
Sample size, blinding, and who paid for it. Those three questions kill most of the confidence in most of these threads.
The measured outcome and the hoped-for outcome are rarely the same thing in these threads.
What the racetam class does pharmacologically does not require the subjective effect to be large to be real.
Headache is the classic first-week effect and choline usually sorts it.
Anyone got a paper worth reading on this rather than a write-up of a paper?